Condition
Ocular Tumor
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Active Not Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07449195Not ApplicableRecruitingPrimary
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
NCT05051384Not ApplicableActive Not RecruitingPrimary
Superb Microvascular Intraocular Tumor Imaging Study (SMITIS)
NCT03713268Recruiting
Intraoperative OCT Guidance of Intraocular Surgery II
NCT04695015Unknown
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
Showing all 4 trials